Search NEL Online

Sort by relevance:
Search in:

Riedel's thyroiditis in a patient with multiple sclerosis.

Kotilainen P, Airas L, Kojo T, Kurki T, Kataja K, Minn H, Nuutila P.
Case Reports 2005; 26(1): 67-68 PubMed PMID: 15726023 Citation  Keywords:  Adult, Anti-Inflammatory Agents:therapeutic use, Brain:pathology, Female, Humans, Magnetic Resonance Imaging, Methylprednisolone:therapeutic use, Multiple Sclerosis:complications, Thyroiditis, Autoimmune:complications,.   

: Our patient developed Riedel's thyroiditis soon after having an exacerbation of multiple sclerosis (MS). MS has been associated with other autoimmune diseases, including thyroiditis, and both Hashimoto's thyroiditis and subacute thyroiditis have been described in connection with MS. Yet, we are not aware of any other patient reported to have concomitant MS and Riedel's thyroiditis. The association between MS and Riedel's thyroiditis remains obscure but may reflect an autoimmune disorder common to both diseases....

Read abstract  Full text PDF

High incidence of hyperandrogenism-related clinical signs in patients with multiple sclerosis.

Falaschi P, Martocchia A, Proietti A, D'Urso R, Antonini G.
Journal Article 2001; 22(4): 248-250 PubMed PMID: 11524631 Citation  Keywords:  Adult, Contraceptives, Oral:pharmacology, Female, Humans, Hyperandrogenism:complications, Incidence, Italy, Menstruation Disturbances:complications, Multiple Sclerosis:complications, Reference Values,.   

: A mild prevalence of multiple sclerosis (MS) is present in females (2:1). To elucidate the pathogenetic role of sex steroids on the disease, we studied 76 women affected by MS, compared to 50 healthy women (mean age +/- SD, 34.9 +/- 0.9 vs. 33.4 +/- 1.7 years). The menarche was at mean age of 12.3 +/- 0.2 vs. 12.4 +/- 0.2. Interval between menses was 28.0 +/- 0.3 vs 27.8 +/- 0.3 days, with duration of menstrual flow of 5.0 +/- 0.2 vs. 5.0 +/- 0.2 days. Oligo- or amenorrhea was present in 20% of patients and in 16% of controls. Oral contraceptives were assumed by 21% of patients and 34% of controls (n.s.). Premenstrual symptoms were found in 43% of patients and in 46% of controls (n.s.). The incidence of hyperandrogenism (greasy skin, acne and hirsutism), evaluated by a specific questionnaire, was higher and statistically significant in MS patients than in controls (28% vs. 10%, p<0.05). Further studies, including a complete clinical and laboratory evaluation of gonadal function, are necessary in order to clarify whether hyperandrogenism may influence MS disease activity....

Read abstract  Full text PDF